Hydroxocobalamin acts as a coenzyme in various metabolic pathways, aiding in DNA synthesis, red blood cell maturation, and neurological function
In fact, by accelerated approval pathway, in 2024 FDA approved Rezdiffra (Resmetirom) as the first (and only) approved treatment for NASH with moderate to advanced liver scarring (fibrosis), without cirrhosis of the liver, along with diet and exercise
Lifestyle factors such as stress, smoking, too much alcohol, poor sleep and major life events contribute to hair loss
Author Contributions Mette JF Nielsen, Britt W Lauenborg and Viera Kupov contributed to the design, protocol and conduct of the studies